New Releases from NCBI BookshelfRemdesivir (Veklury): Indication: For the treatment of coronavirus disease 2019 in nonhospitalized adults and pediatric patients (weighing at least 40 kg) with positive results of direct severe acute respiratory syndrome coronavirus 2 viral testing, and who are at high-risk for progression to severe COVID-19, including hospitalization and death: CADTH Reimbursement Recommendation [Internet].​Remdesivir (Veklury): Indication: For the treatment of coronavirus disease 2019 in nonhospitalized adults and pediatric patients (weighing at least 40 kg) with positive results of direct severe acute respiratory syndrome coronavirus 2 viral testing, and who are at high-risk for progression to severe COVID-19, including hospitalization and death: CADTH Reimbursement Recommendation [Internet].